 | • レポートコード：MRC2Q12-19293 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、経口フィナステリド錠のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 経口フィナステリド錠のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 経口フィナステリド錠の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 経口フィナステリド錠のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの経口フィナステリド錠の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の経口フィナステリド錠の売上および2028年までの予測に焦点を当てています。 経口フィナステリド錠のグローバル主要企業には、Merck、Sandoz、Actavis、Cipla、RelonChem、Dr. Reddy、Accord Pharmaceuticals、Hangzhou Kangenbei Pharmaceutical Co., Ltd、Hunan Zhengqing Pharmaceutical Group Co., Ltd、Tianfang Pharmaceutical Co., Ltd、Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd、Zhejiang Xianju Pharmaceutical Co., Ltd、Shanghai Hyundai Pharmaceutical Co., Ltd、Hunan Baicao Pharmaceutical Co., Ltd、Guangdong Yishu Pharmaceutical Co., Ltd、CR SECCO Pharmaceutical Co., Ltd、Shanghai Xinya Pharmaceutical Minhang Co., Ltd、Renhetang Pharmaceutical Company Limited、Runenberg Pharmaceuticals Ltd、Nanjing Shenghe Pharmaceutical Co., Ltd、Nanjing Sea Whale Pharmaceutical Co., Ltdなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 経口フィナステリド錠市場は、タイプとアプリケーションによって区分されます。世界の経口フィナステリド錠市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 1mg、5mg 【アプリケーション別セグメント】 泌尿器科、皮膚科 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 経口フィナステリド錠製品概要 - タイプ別市場（1mg、5mg） - アプリケーション別市場（泌尿器科、皮膚科） - 調査の目的 ・エグゼクティブサマリー - 世界の経口フィナステリド錠販売量予測2017-2028 - 世界の経口フィナステリド錠売上予測2017-2028 - 経口フィナステリド錠の地域別販売量 - 経口フィナステリド錠の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別経口フィナステリド錠販売量 - 主要メーカー別経口フィナステリド錠売上 - 主要メーカー別経口フィナステリド錠価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（1mg、5mg） - 経口フィナステリド錠のタイプ別販売量 - 経口フィナステリド錠のタイプ別売上 - 経口フィナステリド錠のタイプ別価格 ・アプリケーション別市場規模（泌尿器科、皮膚科） - 経口フィナステリド錠のアプリケーション別販売量 - 経口フィナステリド錠のアプリケーション別売上 - 経口フィナステリド錠のアプリケーション別価格 ・北米市場 - 北米の経口フィナステリド錠市場規模（タイプ別、アプリケーション別） - 主要国別の経口フィナステリド錠市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの経口フィナステリド錠市場規模（タイプ別、アプリケーション別） - 主要国別の経口フィナステリド錠市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の経口フィナステリド錠市場規模（タイプ別、アプリケーション別） - 主要国別の経口フィナステリド錠市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の経口フィナステリド錠市場規模（タイプ別、アプリケーション別） - 主要国別の経口フィナステリド錠市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの経口フィナステリド錠市場規模（タイプ別、アプリケーション別） - 主要国別の経口フィナステリド錠市場規模（トルコ、サウジアラビア） ・企業情報 Merck、Sandoz、Actavis、Cipla、RelonChem、Dr. Reddy、Accord Pharmaceuticals、Hangzhou Kangenbei Pharmaceutical Co., Ltd、Hunan Zhengqing Pharmaceutical Group Co., Ltd、Tianfang Pharmaceutical Co., Ltd、Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd、Zhejiang Xianju Pharmaceutical Co., Ltd、Shanghai Hyundai Pharmaceutical Co., Ltd、Hunan Baicao Pharmaceutical Co., Ltd、Guangdong Yishu Pharmaceutical Co., Ltd、CR SECCO Pharmaceutical Co., Ltd、Shanghai Xinya Pharmaceutical Minhang Co., Ltd、Renhetang Pharmaceutical Company Limited、Runenberg Pharmaceuticals Ltd、Nanjing Shenghe Pharmaceutical Co., Ltd、Nanjing Sea Whale Pharmaceutical Co., Ltd ・産業チェーン及び販売チャネル分析 - 経口フィナステリド錠の産業チェーン分析 - 経口フィナステリド錠の原材料 - 経口フィナステリド錠の生産プロセス - 経口フィナステリド錠の販売及びマーケティング - 経口フィナステリド錠の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 経口フィナステリド錠の産業動向 - 経口フィナステリド錠のマーケットドライバー - 経口フィナステリド錠の課題 - 経口フィナステリド錠の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Oral Finasteride Tablet is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Oral Finasteride Tablet is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Oral Finasteride Tablet is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Oral Finasteride Tablet include Merck, Sandoz, Actavis, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Hangzhou Kangenbei Pharmaceutical Co., Ltd and Hunan Zhengqing Pharmaceutical Group Co., Ltd, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Oral Finasteride Tablet manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Oral Finasteride Tablet market. Further, it explains the major drivers and regional dynamics of the global Oral Finasteride Tablet market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Merck
Sandoz
Actavis
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Hangzhou Kangenbei Pharmaceutical Co., Ltd
Hunan Zhengqing Pharmaceutical Group Co., Ltd
Tianfang Pharmaceutical Co., Ltd
Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
Zhejiang Xianju Pharmaceutical Co., Ltd
Shanghai Hyundai Pharmaceutical Co., Ltd
Hunan Baicao Pharmaceutical Co., Ltd
Guangdong Yishu Pharmaceutical Co., Ltd
CR SECCO Pharmaceutical Co., Ltd
Shanghai Xinya Pharmaceutical Minhang Co., Ltd
Renhetang Pharmaceutical Company Limited
Runenberg Pharmaceuticals Ltd
Nanjing Shenghe Pharmaceutical Co., Ltd
Nanjing Sea Whale Pharmaceutical Co., Ltd
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Oral Finasteride Tablet Segment by Type
1mg
5mg
Oral Finasteride Tablet Segment by Application
Urology
Dermatology
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Oral Finasteride Tablet market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Oral Finasteride Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Oral Finasteride Tablet, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Oral Finasteride Tablet, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Oral Finasteride Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Oral Finasteride Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Oral Finasteride Tablet sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Sandoz, Actavis, Cipla, RelonChem, Dr. Reddy, Accord Pharmaceuticals, Hangzhou Kangenbei Pharmaceutical Co., Ltd and Hunan Zhengqing Pharmaceutical Group Co., Ltd, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Oral Finasteride Tablet in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Oral Finasteride Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Finasteride Tablet sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Oral Finasteride Tablet Product Introduction
1.2 Market by Type
1.2.1 Global Oral Finasteride Tablet Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 1mg
1.2.3 5mg
1.3 Market by Application
1.3.1 Global Oral Finasteride Tablet Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Urology
1.3.3 Dermatology
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oral Finasteride Tablet Sales Estimates and Forecasts 2017-2028
2.2 Global Oral Finasteride Tablet Revenue Estimates and Forecasts 2017-2028
2.3 Global Oral Finasteride Tablet Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Oral Finasteride Tablet Sales by Region
2.4.1 Global Oral Finasteride Tablet Sales by Region (2017-2022)
2.4.2 Global Sales Oral Finasteride Tablet by Region (2023-2028)
2.5 Global Oral Finasteride Tablet Revenue by Region
2.5.1 Global Oral Finasteride Tablet Revenue by Region (2017-2022)
2.5.2 Global Oral Finasteride Tablet Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Oral Finasteride Tablet Sales by Manufacturers
3.1.1 Global Top Oral Finasteride Tablet Manufacturers by Sales (2017-2022)
3.1.2 Global Oral Finasteride Tablet Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Oral Finasteride Tablet in 2021
3.2 Global Oral Finasteride Tablet Revenue by Manufacturers
3.2.1 Global Oral Finasteride Tablet Revenue by Manufacturers (2017-2022)
3.2.2 Global Oral Finasteride Tablet Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Oral Finasteride Tablet Revenue in 2021
3.3 Global Oral Finasteride Tablet Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Oral Finasteride Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Oral Finasteride Tablet Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Oral Finasteride Tablet Sales by Type
4.1.1 Global Oral Finasteride Tablet Historical Sales by Type (2017-2022)
4.1.2 Global Oral Finasteride Tablet Forecasted Sales by Type (2023-2028)
4.1.3 Global Oral Finasteride Tablet Sales Market Share by Type (2017-2028)
4.2 Global Oral Finasteride Tablet Revenue by Type
4.2.1 Global Oral Finasteride Tablet Historical Revenue by Type (2017-2022)
4.2.2 Global Oral Finasteride Tablet Forecasted Revenue by Type (2023-2028)
4.2.3 Global Oral Finasteride Tablet Revenue Market Share by Type (2017-2028)
4.3 Global Oral Finasteride Tablet Price by Type
4.3.1 Global Oral Finasteride Tablet Price by Type (2017-2022)
4.3.2 Global Oral Finasteride Tablet Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Oral Finasteride Tablet Sales by Application
5.1.1 Global Oral Finasteride Tablet Historical Sales by Application (2017-2022)
5.1.2 Global Oral Finasteride Tablet Forecasted Sales by Application (2023-2028)
5.1.3 Global Oral Finasteride Tablet Sales Market Share by Application (2017-2028)
5.2 Global Oral Finasteride Tablet Revenue by Application
5.2.1 Global Oral Finasteride Tablet Historical Revenue by Application (2017-2022)
5.2.2 Global Oral Finasteride Tablet Forecasted Revenue by Application (2023-2028)
5.2.3 Global Oral Finasteride Tablet Revenue Market Share by Application (2017-2028)
5.3 Global Oral Finasteride Tablet Price by Application
5.3.1 Global Oral Finasteride Tablet Price by Application (2017-2022)
5.3.2 Global Oral Finasteride Tablet Price Forecast by Application (2023-2028)
6 North America
6.1 North America Oral Finasteride Tablet Market Size by Type
6.1.1 North America Oral Finasteride Tablet Sales by Type (2017-2028)
6.1.2 North America Oral Finasteride Tablet Revenue by Type (2017-2028)
6.2 North America Oral Finasteride Tablet Market Size by Application
6.2.1 North America Oral Finasteride Tablet Sales by Application (2017-2028)
6.2.2 North America Oral Finasteride Tablet Revenue by Application (2017-2028)
6.3 North America Oral Finasteride Tablet Market Size by Country
6.3.1 North America Oral Finasteride Tablet Sales by Country (2017-2028)
6.3.2 North America Oral Finasteride Tablet Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Oral Finasteride Tablet Market Size by Type
7.1.1 Europe Oral Finasteride Tablet Sales by Type (2017-2028)
7.1.2 Europe Oral Finasteride Tablet Revenue by Type (2017-2028)
7.2 Europe Oral Finasteride Tablet Market Size by Application
7.2.1 Europe Oral Finasteride Tablet Sales by Application (2017-2028)
7.2.2 Europe Oral Finasteride Tablet Revenue by Application (2017-2028)
7.3 Europe Oral Finasteride Tablet Market Size by Country
7.3.1 Europe Oral Finasteride Tablet Sales by Country (2017-2028)
7.3.2 Europe Oral Finasteride Tablet Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Oral Finasteride Tablet Market Size by Type
8.1.1 Asia Pacific Oral Finasteride Tablet Sales by Type (2017-2028)
8.1.2 Asia Pacific Oral Finasteride Tablet Revenue by Type (2017-2028)
8.2 Asia Pacific Oral Finasteride Tablet Market Size by Application
8.2.1 Asia Pacific Oral Finasteride Tablet Sales by Application (2017-2028)
8.2.2 Asia Pacific Oral Finasteride Tablet Revenue by Application (2017-2028)
8.3 Asia Pacific Oral Finasteride Tablet Market Size by Region
8.3.1 Asia Pacific Oral Finasteride Tablet Sales by Region (2017-2028)
8.3.2 Asia Pacific Oral Finasteride Tablet Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Oral Finasteride Tablet Market Size by Type
9.1.1 Latin America Oral Finasteride Tablet Sales by Type (2017-2028)
9.1.2 Latin America Oral Finasteride Tablet Revenue by Type (2017-2028)
9.2 Latin America Oral Finasteride Tablet Market Size by Application
9.2.1 Latin America Oral Finasteride Tablet Sales by Application (2017-2028)
9.2.2 Latin America Oral Finasteride Tablet Revenue by Application (2017-2028)
9.3 Latin America Oral Finasteride Tablet Market Size by Country
9.3.1 Latin America Oral Finasteride Tablet Sales by Country (2017-2028)
9.3.2 Latin America Oral Finasteride Tablet Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Oral Finasteride Tablet Market Size by Type
10.1.1 Middle East and Africa Oral Finasteride Tablet Sales by Type (2017-2028)
10.1.2 Middle East and Africa Oral Finasteride Tablet Revenue by Type (2017-2028)
10.2 Middle East and Africa Oral Finasteride Tablet Market Size by Application
10.2.1 Middle East and Africa Oral Finasteride Tablet Sales by Application (2017-2028)
10.2.2 Middle East and Africa Oral Finasteride Tablet Revenue by Application (2017-2028)
10.3 Middle East and Africa Oral Finasteride Tablet Market Size by Country
10.3.1 Middle East and Africa Oral Finasteride Tablet Sales by Country (2017-2028)
10.3.2 Middle East and Africa Oral Finasteride Tablet Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Sandoz
11.2.1 Sandoz Corporation Information
11.2.2 Sandoz Overview
11.2.3 Sandoz Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sandoz Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sandoz Recent Developments
11.3 Actavis
11.3.1 Actavis Corporation Information
11.3.2 Actavis Overview
11.3.3 Actavis Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Actavis Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Actavis Recent Developments
11.4 Cipla
11.4.1 Cipla Corporation Information
11.4.2 Cipla Overview
11.4.3 Cipla Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cipla Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Recent Developments
11.5 RelonChem
11.5.1 RelonChem Corporation Information
11.5.2 RelonChem Overview
11.5.3 RelonChem Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 RelonChem Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 RelonChem Recent Developments
11.6 Dr. Reddy
11.6.1 Dr. Reddy Corporation Information
11.6.2 Dr. Reddy Overview
11.6.3 Dr. Reddy Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Dr. Reddy Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dr. Reddy Recent Developments
11.7 Accord Pharmaceuticals
11.7.1 Accord Pharmaceuticals Corporation Information
11.7.2 Accord Pharmaceuticals Overview
11.7.3 Accord Pharmaceuticals Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Accord Pharmaceuticals Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Accord Pharmaceuticals Recent Developments
11.8 Hangzhou Kangenbei Pharmaceutical Co., Ltd
11.8.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Corporation Information
11.8.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Overview
11.8.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments
11.9 Hunan Zhengqing Pharmaceutical Group Co., Ltd
11.9.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Corporation Information
11.9.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Overview
11.9.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments
11.10 Tianfang Pharmaceutical Co., Ltd
11.10.1 Tianfang Pharmaceutical Co., Ltd Corporation Information
11.10.2 Tianfang Pharmaceutical Co., Ltd Overview
11.10.3 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
11.11 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
11.11.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Corporation Information
11.11.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Overview
11.11.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments
11.12 Zhejiang Xianju Pharmaceutical Co., Ltd
11.12.1 Zhejiang Xianju Pharmaceutical Co., Ltd Corporation Information
11.12.2 Zhejiang Xianju Pharmaceutical Co., Ltd Overview
11.12.3 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments
11.13 Shanghai Hyundai Pharmaceutical Co., Ltd
11.13.1 Shanghai Hyundai Pharmaceutical Co., Ltd Corporation Information
11.13.2 Shanghai Hyundai Pharmaceutical Co., Ltd Overview
11.13.3 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments
11.14 Hunan Baicao Pharmaceutical Co., Ltd
11.14.1 Hunan Baicao Pharmaceutical Co., Ltd Corporation Information
11.14.2 Hunan Baicao Pharmaceutical Co., Ltd Overview
11.14.3 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments
11.15 Guangdong Yishu Pharmaceutical Co., Ltd
11.15.1 Guangdong Yishu Pharmaceutical Co., Ltd Corporation Information
11.15.2 Guangdong Yishu Pharmaceutical Co., Ltd Overview
11.15.3 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments
11.16 CR SECCO Pharmaceutical Co., Ltd
11.16.1 CR SECCO Pharmaceutical Co., Ltd Corporation Information
11.16.2 CR SECCO Pharmaceutical Co., Ltd Overview
11.16.3 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments
11.17 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
11.17.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Corporation Information
11.17.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Overview
11.17.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments
11.18 Renhetang Pharmaceutical Company Limited
11.18.1 Renhetang Pharmaceutical Company Limited Corporation Information
11.18.2 Renhetang Pharmaceutical Company Limited Overview
11.18.3 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Renhetang Pharmaceutical Company Limited Recent Developments
11.19 Runenberg Pharmaceuticals Ltd
11.19.1 Runenberg Pharmaceuticals Ltd Corporation Information
11.19.2 Runenberg Pharmaceuticals Ltd Overview
11.19.3 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Runenberg Pharmaceuticals Ltd Recent Developments
11.20 Nanjing Shenghe Pharmaceutical Co., Ltd
11.20.1 Nanjing Shenghe Pharmaceutical Co., Ltd Corporation Information
11.20.2 Nanjing Shenghe Pharmaceutical Co., Ltd Overview
11.20.3 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments
11.21 Nanjing Sea Whale Pharmaceutical Co., Ltd
11.21.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Corporation Information
11.21.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Overview
11.21.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Oral Finasteride Tablet Industry Chain Analysis
12.2 Oral Finasteride Tablet Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Oral Finasteride Tablet Production Mode & Process
12.4 Oral Finasteride Tablet Sales and Marketing
12.4.1 Oral Finasteride Tablet Sales Channels
12.4.2 Oral Finasteride Tablet Distributors
12.5 Oral Finasteride Tablet Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Oral Finasteride Tablet Industry Trends
13.2 Oral Finasteride Tablet Market Drivers
13.3 Oral Finasteride Tablet Market Challenges
13.4 Oral Finasteride Tablet Market Restraints
14 Key Findings in The Global Oral Finasteride Tablet Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer